| Application no. and date | 18198653.0 (espacenet) (Federated) (European Patent Register), 20151007 | | Patent/reg. no. and date | DK/EP 3456330, 20210519 | | Publication date | 20190320 | | Priority no. and date | EP 14188063, 20141008 | | EP pub. no. and date |
EP 3456330 20190320 | | Effective date | | | Applicant/owner | Cosmo Technologies Ltd, Riverside II
Sir John Rogerson's Quay,
Dublin 2, IE | | Applicant ref. no. | 164881/BT/MC | | Inventor | Gerloni, Mara, 2933 Ariane Drive
San Diego, CA 92117, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) , A61P 43/00 (2006.01) , A61P 5/46 (2006.01) , C07J 5/00 (2006.01) | | Title | CORTEXOLON-17ALPHA-VALERAT TIL ANVENDELSE VED BEHANDLING AF TUMORER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
